Skip to main content
. Author manuscript; available in PMC: 2019 May 15.
Published in final edited form as: Clin Cancer Res. 2018 Feb 20;24(10):2408–2416. doi: 10.1158/1078-0432.CCR-17-3474

Figure 1. Transcriptome analysis of LNCaP-AR human prostate cancer xenografts post-VTP treatment.

Figure 1

(A) Top ranked GSEA pathways among the gene sets HALLMARK and Canonical Pathways (C2). (B) Enrichment plots with normalized enrichment scores (NES) for androgen response pathways within both gene sets at 6 hr post-VTP (n=4) vs. control (n=4).